Strategic Investments Beyond Celiac’s venture philanthropy arm actively invests in celiac therapeutics and related biotech ventures, indicating a potential for partnership discussions, co-investment opportunities, and access to a network of portfolio companies needing alliance or advocacy support.

Clinical Collaboration With recent leadership updates including a new President and CSO, and a focus on accelerating research and clinical trials, there is an opening to offer clinical trial recruitment services, research partnerships, and data collaboration to support trial sites and patient enrollment.

Tech & Analytics Existing tech stack spans CRM, analytics, content management and performance optimization tools, suggesting readiness for partnerships around digital engagement, patient-facing portals, data capture, and analytics services or platform enhancements.

Industry Visibility Active participation in global events and high-profile symposia alongside ongoing research highlights positions Beyond Celiac as a channel for conference sponsorship, speaker engagements, and collaborative research communications to raise awareness and drive support.

Revenue & Growth Funding scale reported at ten to twenty-five million dollars with ongoing investments in therapeutics signals a growing organization with budget for strategic partnerships, sponsorships, grant-based programs, or sponsored research agreements.